Actively Recruiting
Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition
Led by Yuhan Corporation · Updated on 2025-01-07
60
Participants Needed
5
Research Sites
32 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition
CONDITIONS
Official Title
Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 19 years or older at screening visit
- Expected need for parenteral nutrition for more than 3 days
- Voluntarily signed informed consent form
You will not qualify if you...
- Expected survival less than 3 days
- Body mass index (BMI) over 30 kg/m2
- Hypersensitivity to peanut, fish, soy, egg proteins, or investigational drugs
- Difficulties with central venous line
- Judged unsuitable for the trial by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
National Cancer Center
Gyeonggi-do, Goyang-si, South Korea, 10408
Actively Recruiting
2
Chonnam National University Hwasun Hospital
Jeollanam-do, Hwasun-gun, South Korea, 58128
Actively Recruiting
3
Jeonbuk National University Hospital
Jeollabuk-do, Jeonju-si, South Korea, 54907
Actively Recruiting
4
Severance Hospital
Seoul, Seodaemun-gu, South Korea, 03722
Actively Recruiting
5
Seoul National University Bundang
Gyeonggi-do, Seongnam-si, South Korea, 13620
Actively Recruiting
Research Team
J
Jinhyun Choi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here